Document Detail

Stereotactic radiosurgery at a low marginal dose for the treatment of pediatric arteriovenous malformations: obliteration, complications, and functional outcomes.
MedLine Citation:
PMID:  24766309     Owner:  NLM     Status:  Publisher    
Object Stereotactic radiosurgery (SRS) is an established treatment modality for brain arteriovenous malformations (AVMs) in children, but the optimal treatment parameters and associated treatment-related complications are not fully understood. The authors present their single-institution experience of using SRS, at a relatively low marginal dose, to treat AVMs in children for nearly 20 years; they report angiographic outcomes, posttreatment hemorrhage rates, adverse treatment-related events, and functional outcomes. Methods The authors conducted a retrospective review of 2 cohorts of children (18 years of age or younger) with AVMs treated from 1991 to 1998 and from 2000 to 2010. Results A total of 80 patients with follow-up data after SRS were identified. Mean age at SRS was 12.7 years, and 56% of patients had hemorrhage at the time of presentation. Median target volume was 3.1 cm(3) (range 0.09-62.3 cm(3)), and median prescription marginal dose used was 17.5 Gy (range 12-20 Gy). Angiograms acquired 3 years after treatment were available for 47% of patients; AVM obliteration was achieved in 52% of patients who received a dose of 18-20 Gy and in 16% who received less than 18 Gy. At 5 years after SRS, the cumulative incidence of hemorrhage was 25% (95% CI 16%-37%). No permanent neurological deficits occurred in patients who did not experience posttreatment hemorrhage. Overall, good functional outcomes (modified Rankin Scale Scores 0-2) were observed for 78% of patients; for 66% of patients, functional status improved or remained the same as before treatment. Conclusions A low marginal dose minimizes SRS-related neurological deficits but leads to low rates of obliteration and high rates of hemorrhage. To maximize AVM obliteration and minimize posttreatment hemorrhage, the authors recommend a prescription marginal dose of 18 Gy or more. In addition, SRS-related symptoms such as headache and seizures should be considered when discussing risks and benefits of SRS for treating AVMs in children.
Matthew B Potts; Sunil A Sheth; Jonathan Louie; Matthew D Smyth; Penny K Sneed; Michael W McDermott; Michael T Lawton; William L Young; Steven W Hetts; Heather J Fullerton; Nalin Gupta
Related Documents :
23944209 - Effects of non-invasive ventilation on reintubation rate: a systematic review and meta-...
23250049 - Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haem...
24698569 - What is the most reliable solid culture medium for tuberculosis treatment trials?
24560649 - Strategy and long-term outcomes of endovascular treatment for budd-chiari syndrome comp...
24682279 - Role of thyroid surgery in the obstructive sleep apnea syndrome.
23881439 - Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial.
15152959 - Diagnosis and treatment of acne.
8989299 - Illness behavior influences the outcome of laparoscopic antireflux surgery.
8318819 - Recurrence of destructive periodontal disease after treatment. a long term study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-25
Journal Detail:
Title:  Journal of neurosurgery. Pediatrics     Volume:  -     ISSN:  1933-0715     ISO Abbreviation:  J Neurosurg Pediatr     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101463759     Medline TA:  J Neurosurg Pediatr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quality measurement in the shunt treatment of hydrocephalus: analysis and risk adjustment of the Rev...
Next Document:  Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous...